The NASH liver disease treatment market is growing with biotech companies like Intercept and Genfit in late-stage tests. Experts say the market for a successful drug could be worth billions.

source https://finance.yahoo.com/m/8f1b4e7d-774c-3603-acf6-24dfd6d409da/obesity-epidemic-leads-to-a.html?.tsrc=rss